Literature DB >> 23640496

p21 activated kinase signaling coordinates glycoprotein receptor VI-mediated platelet aggregation, lamellipodia formation, and aggregate stability under shear.

Joseph E Aslan1, Asako Itakura, Kristina M Haley, Garth W Tormoen, Cassandra P Loren, Sandra M Baker, Jiaqing Pang, Jonathan Chernoff, Owen J T McCarty.   

Abstract

OBJECTIVE: Rho GTPase proteins play a central role in regulating the dynamics of the platelet actin cytoskeleton. Yet, little is known regarding how Rho GTPase activation coordinates platelet activation and function. In this study, we aimed to characterize the role of the Rho GTPase effector, p21 activated kinase (PAK), in platelet activation, lamellipodia formation, and aggregate formation under shear. APPROACH AND
RESULTS: Stimulation of platelets with the glycoprotein receptor VI agonist, collagen-related peptide, rapidly activated PAK in a time course preceding phosphorylation of PAK substrates, LIM domain kinase LIMK1 and the MAPK/ERK kinase MEK, and the subsequent activation of MAPKs and Akt. Pharmacological inhibitors of PAK blocked signaling events downstream of PAK and prevented platelet secretion as well as platelet aggregation in response to collagen-related peptide. PAK inhibitors also prevented PAK activation and platelet spreading on collagen surfaces. PAK was also required for the formation of platelet aggregates and to maintain aggregate stability under physiological shear flow conditions.
CONCLUSIONS: These results suggest that PAK serves as an orchestrator of platelet functional responses after activation downstream of the platelet collagen receptor, glycoprotein receptor VI.

Entities:  

Keywords:  cell signaling; platelet; signal transduction

Mesh:

Substances:

Year:  2013        PMID: 23640496      PMCID: PMC3938029          DOI: 10.1161/ATVBAHA.112.301165

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  47 in total

Review 1.  Thrombus formation in vivo.

Authors:  Bruce Furie; Barbara C Furie
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

Review 2.  A tale of two Paks.

Authors:  Luis E Arias-Romero; Jonathan Chernoff
Journal:  Biol Cell       Date:  2008-02       Impact factor: 4.458

3.  Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth.

Authors:  Brion W Murray; Chuangxing Guo; Joseph Piraino; John K Westwick; Cathy Zhang; Jane Lamerdin; Eleanor Dagostino; Daniel Knighton; Cho-Ming Loi; Michael Zager; Eugenia Kraynov; Ian Popoff; James G Christensen; Ricardo Martinez; Susan E Kephart; Joseph Marakovits; Shannon Karlicek; Simon Bergqvist; Tod Smeal
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-03       Impact factor: 11.205

4.  Arp2/3 complex is required for actin polymerization during platelet shape change.

Authors:  Zhi Li; Eric S Kim; Elaine L Bearer
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

Review 5.  Lim kinases, regulators of actin dynamics.

Authors:  Ora Bernard
Journal:  Int J Biochem Cell Biol       Date:  2006-11-28       Impact factor: 5.085

6.  MEK1 activation by PAK: a novel mechanism.

Authors:  Electa R Park; Scott T Eblen; Andrew D Catling
Journal:  Cell Signal       Date:  2007-01-24       Impact factor: 4.315

7.  Identification and molecular cloning of a p21cdc42/rac1-activated serine/threonine kinase that is rapidly activated by thrombin in platelets.

Authors:  M Teo; E Manser; L Lim
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

Review 8.  Rho GTPases in platelet function.

Authors:  J E Aslan; O J T McCarty
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

Review 9.  Antiplatelet therapy: in search of the 'magic bullet'.

Authors:  Shaun P Jackson; Simone M Schoenwaelder
Journal:  Nat Rev Drug Discov       Date:  2003-10       Impact factor: 84.694

10.  Regulation of Akt/PKB activity by P21-activated kinase in cardiomyocytes.

Authors:  Kai Mao; Satoru Kobayashi; Zahara M Jaffer; Yuan Huang; Paul Volden; Jonathan Chernoff; Qiangrong Liang
Journal:  J Mol Cell Cardiol       Date:  2007-12-03       Impact factor: 5.000

View more
  20 in total

1.  Histone deacetylase 6-mediated deacetylation of α-tubulin coordinates cytoskeletal and signaling events during platelet activation.

Authors:  Joseph E Aslan; Kevin G Phillips; Laura D Healy; Asako Itakura; Jiaqing Pang; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2013-09-11       Impact factor: 4.249

2.  The p21-activated kinase, PAK2, is important in the activation of numerous pancreatic acinar cell signaling cascades and in the onset of early pancreatitis events.

Authors:  Bernardo Nuche-Berenguer; Irene Ramos-Álvarez; R T Jensen
Journal:  Biochim Biophys Acta       Date:  2016-02-18

3.  Gq-mediated Akt translocation to the membrane: a novel PIP3-independent mechanism in platelets.

Authors:  Rachit Badolia; Bhanu Kanth Manne; Carol Dangelmaier; Jonathan Chernoff; Satya P Kunapuli
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

4.  Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs.

Authors:  Özgün Babur; Alexander R Melrose; Jennifer M Cunliffe; John Klimek; Jiaqing Pang; Anna-Liisa I Sepp; Jevgenia Zilberman-Rudenko; Samuel Tassi Yunga; Tony Zheng; Iván Parra-Izquierdo; Jessica Minnier; Owen J T McCarty; Emek Demir; Ashok P Reddy; Phillip A Wilmarth; Larry L David; Joseph E Aslan
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

5.  Assessment of roles for the Rho-specific guanine nucleotide dissociation inhibitor Ly-GDI in platelet function: a spatial systems approach.

Authors:  Anh T P Ngo; Marisa L D Thierheimer; Özgün Babur; Anne D Rocheleau; Tao Huang; Jiaqing Pang; Rachel A Rigg; Annachiara Mitrugno; Dan Theodorescu; Julja Burchard; Xiaolin Nan; Emek Demir; Owen J T McCarty; Joseph E Aslan
Journal:  Am J Physiol Cell Physiol       Date:  2017-02-01       Impact factor: 4.249

Review 6.  P21-activated kinase in inflammatory and cardiovascular disease.

Authors:  Domenico M Taglieri; Masuko Ushio-Fukai; Michelle M Monasky
Journal:  Cell Signal       Date:  2014-05-02       Impact factor: 4.315

7.  Pak2 restrains endomitosis during megakaryopoiesis and alters cytoskeleton organization.

Authors:  Rachelle E Kosoff; Joseph E Aslan; John C Kostyak; Essel Dulaimi; Hoi Yee Chow; Tatiana Y Prudnikova; Maria Radu; Satya P Kunapuli; Owen J T McCarty; Jonathan Chernoff
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

8.  Potentiation of TRAP-6-induced platelet dense granule release by blockade of P2Y12 signaling with MRS2395.

Authors:  Annachiara Mitrugno; Rachel A Rigg; Nicole B Laschober; Anh T P Ngo; Jiaqing Pang; Craig D Williams; Joseph E Aslan; Owen J T McCarty
Journal:  Platelets       Date:  2017-05-19       Impact factor: 3.862

9.  Oral administration of Bruton's tyrosine kinase inhibitors impairs GPVI-mediated platelet function.

Authors:  Rachel A Rigg; Joseph E Aslan; Laura D Healy; Michael Wallisch; Marisa L D Thierheimer; Cassandra P Loren; Jiaqing Pang; Monica T Hinds; András Gruber; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2015-12-09       Impact factor: 4.249

10.  Lysine acetyltransfer supports platelet function.

Authors:  J E Aslan; R A Rigg; M S Nowak; C P Loren; S M Baker-Groberg; J Pang; L L David; O J T McCarty
Journal:  J Thromb Haemost       Date:  2015-08-29       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.